CLINICAL_TRIALS
trial_result
· 2021-07-16
Clinical Trial Update: Daratumumab in Treatment of PGNMID and C3 GN [Phase 2]
Summary
Phase 2 trial update for daratumumab in membranoproliferative glomerulonephritis showing completed status with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fernando Fervenza | Conditions: Membranoproliferative Glomerulonephritis | Phase 2 | Status: COMPLETED | Results posted: 2021-07-16